Ueno, US
Kaoru Ueno, Escondido, CA US
Patent application number | Description | Published |
---|---|---|
20130089946 | WAVELENGTH CONVERSION FILM HAVING PRESSURE SENSITIVE ADHESIVE LAYER TO ENHANCE SOLAR HARVESTING EFFICIENCY - Described herein are wavelength conversion films that are easy-to-apply to solar cells, solar panels, or photovoltaic devices using an adhesive layer. The wavelength conversion films include a wavelength conversion layer with a photostable chromophore and are useful for improving the solar harvesting efficiency of solar cells, solar panels, and photovoltaic devices. | 04-11-2013 |
20130139868 | WAVELENGTH CONVERSION MATERIAL AS ENCAPSULATE FOR SOLAR MODULE SYSTEMS TO ENHANCE SOLAR HARVESTING EFFICIENCY - This invention relates to an encapsulation structure comprising a luminescent wavelength conversion material for at least one solar cell or photovoltaic device which acts to enhance the solar harvesting efficiency of the solar cell device. The luminescent wavelength conversion material comprises at least one chromophore and an optically transparent polymer matrix. Application of the encapsulation structure, as disclosed herein, to solar harvesting devices, including solar cells, solar panels, and photovoltaic devices, improves the solar harvesting efficiency of the device by widening the spectrum of incoming sunlight that can be effectively converted into electricity by the device. | 06-06-2013 |
Makoto Ueno, Canoga Park, CA US
Patent application number | Description | Published |
---|---|---|
20120251092 | Articulated Sensor Support Structure - Embodiments include an assembly comprising: (a) a camera support structure comprising: a masthead disposed on the distal end of a mast wherein the masthead is configured to receive an imaging element; where a proximal end of the mast rotatably engaging an azimuth-elevation joint assembly wherein the azimuth-elevation joint assembly comprises a first angular actuator of a first rotational degree-of-freedom and a second angular actuator of a second rotational degree of freedom; and (b) a camera support structure housing comprising an aperture and a hatch wherein the hatch is resiliently biased to close the aperture; and wherein the camera support structure is configured to overcome the hatch resilient bias by at least one of: the release of a pin restraining a loaded spring and a rotational actuation of the mast via at least one of the first angular actuator and the second angular actuator. | 10-04-2012 |
Mariko Ueno, Elizabeth, NJ US
Patent application number | Description | Published |
---|---|---|
20150216323 | Waist-Mounted Baby Harness - A baby harness is designed to concentrate the infant's weight on the waist and hips rather than on the neck and shoulder area, which is typical of conventional baby harnesses. This design enables the parent to remain active in terms of being hands-free and allowing bending from the waist. The harness secures the baby to the parent's lower back/waist/buttocks area by two cooperating tapered belt components which are extensions of the harness itself. The seat component of the harness comprises a concave enclosure providing bottom, back and head support. The seat component has bilateral extensions containing four openings through which the infant's arms and legs project, thereby securing both the upper and lower body of the child while also allowing free movement of the baby's limbs. The bilateral extensions taper toward the front of the harness and transition into the two cooperating belt components that connect around the parent's waist, so that the belt also contributes to stabilizing the infant's body weight distribution. | 08-06-2015 |
Naoto T. Ueno, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20120329061 | QUANTITATIVE RT-PCR DETECTION FOR GENES INVOLVED IN EPITHELIAL MESENCHYMAL TRANSITION IN PERIPHERAL BLOOD OF CANCER PATIENTS - An assay and associated methodologies for detection of breast cancer are described. Circulating tumor cells (“CTCs”) undergo epithelial mesenchymal transition (“EMT”) prior to entering circulation, resulting in the loss of epithelial markers. These CTCs and EMT-related gene transcripts in the peripheral blood of patients are tested by quantitative RT-PCR to detect and diagnose breast cancer. | 12-27-2012 |
Ryuji Ueno, Saint Michaels, MD US
Patent application number | Description | Published |
---|---|---|
20140363458 | MALARIA VACCINE - The present invention provides a particle comprising a polypeptide and at least one malaria antigen, and a composition or vaccine comprising thereof, its use in medicine, particularly in the prevention or treatment of malaria infections. | 12-11-2014 |
20150057351 | METHOD FOR TREATING NEUROPATHIC PAIN - A method for treating neuropathic pain in a mammalian subject, which comprises administering an effective amount of a fatty acid derivative, is provided. | 02-26-2015 |
Ryuji Ueno, St. Michaels, MD US
Patent application number | Description | Published |
---|---|---|
20140371304 | METHOD FOR SUPPRESSING TUMORIGENICITY OF STEM CELLS - A method for suppressing tumorigenicity of stem cells in a mammalian subject, which comprises administering an effective amount of a fatty acid derivative and a method for suppressing tumorigenicity of stem cells of a mammalian subject, which comprises contacting said stem cell with an effective amount of a fatty acid derivative, are provided. | 12-18-2014 |
20150017194 | VIRUS LIKE PARTICLE COMPRISING PD-1 ANTIGEN OR PD-1 LIGAND ANTIGEN - The present invention provides a virus like particle comprising a virus structural protein and an antigen derived from PD-1 or a ligand of PD-1, and a composition or kit comprising thereof, its use in immune response etc. | 01-15-2015 |
Ryuji Ueno, Easton, MD US
Patent application number | Description | Published |
---|---|---|
20150099802 | SELECTIVE TUMOR TREATMENT - A method for treating a tumor with a decreased level of the 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a fatty acid derivative, a method for suppressing the growth of a tumor cell with a decreased level of the 15-hydroxy-prostaglandin dehydrogenase (15-PGDH), which comprises contacting said tumor cell with an effective amount of a fatty acid derivative, and a method for identifying a subject who would be responsive to a fatty acid derivative, comprising, (i) obtaining a biological sample from said subject; and (ii) measuring 15-hydroxyprostaglandin dehydrogenase (15-PGDH) level are provided. | 04-09-2015 |
20150126609 | PHARMACEUTICAL COMPOSITION COMPRISING 11-DEOXY -PROSTAGLANDIN COMPOUND AND METHOD FOR STABILIZING THE COMPOUND - Provided is a pharmaceutical composition including an 11-deoxy-prostaglandin compound represented by formula (I): | 05-07-2015 |